发明名称 3, 4-DIHYDROXYBENZALACETONE FOR THE ACTIVATION OF ANTIOXIDANT PROTEIN NRF-2, THE TREATMENT AND PREVENTION OF HEPATITIS OR LIVER PROTECTION
摘要 PURPOSE: A composition containing 3,4-dihydroxybenzalacetone is provided to enhance Nrf-2 activation and to suppress hepatitis with anti-aging and high immunity. CONSTITUTION: A composition used for preventing or relieving disease by enhancing Nrf-2 activation contains 3,4-dihydroxybenzalacetone(DBL). The diseases which can be relieved by enhancing Nrf-2 activation is artery scleroma, hypertension, diabetes, central nervous system disease, skin disease, eye trauma, asthma, cancer, or inflammation, inflammation, or liver injury. A composition for preventing or treating hepatitis contains DBL. The composition is administered in the form of powder, tablet, injection, health food capsule or health beverage.
申请公布号 KR20100137748(A) 申请公布日期 2010.12.31
申请号 KR20090055950 申请日期 2009.06.23
申请人 ILDONG PHARM CO., LTD. 发明人 KO, JONG HEE;YEON, SEUNG WOO;PARK, EUN KYUNG;RYU, JUNG SU;BAEK, NAM IN;KANG, JAE HOON
分类号 A61K31/12;A61P1/16;A61P9/10;A61P9/12 主分类号 A61K31/12
代理机构 代理人
主权项
地址